Nifedipine--a new antianginal agent
Stern, Z.; Levy, M.
Harefuah 100(10): 494-496
1981
ISSN/ISBN: 0017-7768 PMID: 7308894 Document Number: 169059
Document emailed within 1 workday
Related Documents
Mérillon, J.P.; Morgant, C.; Zygelman, M.; Beaufils, P.; Patart, O.; Chapuy, J.Y.; Gourgon, R. 1978: Comparison of hemodynamic and coronary effects of 2 antianginal vasodilator drugs: nifedipine and trinitrine Archives des Maladies du Coeur et des Vaisseaux 71(8): 913-921Laskawiec, G.; Zmudziński, J.; Jamrozik-Kruk, Z. 1993: Bepridil--a new antianginal agent with antiarrhythmic properties Polski Tygodnik Lekarski 48(14-15): 330-332
Tsuboi, T.; Hatano, N.; Nakatsuji, K.; Fujitani, B.; Yoshida, K.; Shimizu, M.; Kawasaki, A.; Sakata, M.; Tsuboshima, M. 1980: Pharmacological evaluation of OP 1206, a prostaglandin E1 derivative, as an antianginal agent Archives Internationales de Pharmacodynamie et de Therapie 247(1): 89-102
Demchenko, E.A.; Berezina, A.V.; Panov, A.V. 2002: Antianginal and anti-ischemic effects of Mono Mac 50D preparation as an agent in combined treatment of patients with stable angina Klinicheskaia Meditsina 80(9): 57-59
Kirby, B.J.; Kitchin, N.R. 1999: A comparison of the effects of two modified release preparations of nifedipine-nifedipine retard 10 mg twice daily and nifedipine GITS 20 mg once daily--in the treatment of mild to moderate hypertension International Journal of Clinical Practice 53(5): 339-343
De Ponti, C.; Mauri, F.; Fiorista, F.; Ciliberto, G.R.; Carù, B.; Rovelli, F. 1977: Effectiveness of nifedipine on exercise tolerance in patients with angina pectoris. Comparison with a nitroderivative and a beta-blocking agent Giornale Italiano di Cardiologia 7(12): 1162-1171
Waghmare, A.; Kanyalkar, M.; Joshi, M.; Srivastava, S. 2011: In-vitro metabolic inhibition and antifertility effect facilitated by membrane alteration: search for novel antifertility agent using nifedipine analogues European Journal of Medicinal Chemistry 46(9): 3581-3589
Lutz, D.; Pabst, G.; Dahmen, W.; Molz, K.H.; Jaeger, H. 1985: Bioavailability of new nifedipine preparations in man. 1. Pharmacokinetics of nifedipine in the form of sustained-release tablets Arzneimittel-Forschung 35(12): 1840-1842
Jiang, H.; Rao, M.R. 1993: Protective effects of m-nifedipine and nifedipine in isolated ischemic-reperfused rat hearts Yao Xue Xue Bao 28(1): 1-5
Chen, N.H.; Rao, M.R. 1989: Protective effects of m-nifedipine and nifedipine on ischemic-reperfused injury in working guinea pig hearts Zhongguo Yao Li Xue Bao 10(2): 156-161
Rao, M.R.; Liang, M.D.; Liu, G.Y.; Liu, F.; Zhang, H.Q. 1984: Effect of m-nifedipine, a calcium antagonist, on cardiac performance and oxygen consumption in anesthetized animal: a comparison with nifedipine Yao Xue Xue Bao 19(2): 101-107
Rao, M.R.; Liu, Q.Y.; Jia, S.L. 1993: Effects of m-nifedipine and nifedipine given intraduodenally on coronary flow, myocardial oxygen, and carbon dioxide metabolism in dogs Zhongguo Yao Li Xue Bao 14(Suppl): S25-S27
Pise, M.; Korukonda, K.Prasad.; Walwaikar, P.P. 2009: Compiled report on clinical efficacy and safety of nifedipine retard 10/20/nifedipine CD 30, as a first-line/add-on therapy in patients of hypertension: ENHANS trial Journal of the Indian Medical Association 107(2): 114-116
Di Filippo, C.; Lampa, E.; Forgione, A.; Capuano, A.; Rossi, F.; D'Amico, M. 2005: Effects of nifedipine controlled release on blood pressure and heart rate of spontaneously hypertensive rats. Comparison with nifedipine standard and with amlodipine Italian Heart Journal. Supplement: Official Journal of the Italian Federation of Cardiology 6(5): 285-290
Hosie, J.; Nasar, M.A.; Belgrave, G.P.; Walters, E.G. 1994: A comparative study of long acting diltiazem (Tildiem LA) with sustained release nifedipine (nifedipine SR) and bendrofluazide in the treatment of mild to moderate hypertension Acta Cardiologica 49(3): 251-265
Tijssen, J.G.; Lubsen, J. 1987: Nifedipine and metoprolol in unstable angina: findings from the Holland Interuniversity Nifedipine/Metoprolol Trial (HINT) Journal of Cardiovascular Pharmacology 10 Suppl. 2: S15
Lichtlen, P.R.; Hugenholtz, P.G.; Rafflenbeul, W.; Hecker, H.; Jost, S.; Deckers, J.W. 1990: Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). INTACT Group Investigators Lancet 335(8698): 1109-1113
Karnik, N.D.; Bhatt, A.D.; Trivedi, T.H.; Dadkar, V.N.; Kapadia, N.M.; Vaidya, A.B.; Khokhani, R.C. 1996: Nifedipine, captopril, metoprolol and nifedipine with metoprolol in hypertensive crisis in non-intensive care setting Journal of the Association of Physicians of India 44(7): 480-482
Chichkanov, G.G.; Chumburidze, V.B. 1977: Mechanism of the antianginal action of oxyfedrine Farmakologiia i Toksikologiia 40(3): 302-306
Piña López-Yllana, C. 1979: Ergometry as a method of evaluation of antianginal drugs Archivos de Farmacologia y Toxicologia 5(3): 231-234